Variant report
Variant | nsv1018895 |
---|---|
Chromosome Location | chr9:9801869-9822041 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KDM4C-10 | chr9:9803717-9803784 | ENSG00000230920 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529167681 | chr9:9803733-9803734 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs144216024 | chr9:9803758-9803759 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs559482759 | chr9:9803765-9803766 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549591883 | chr9:9805220-9805221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4742623 | chr9:9805232-9805233 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs555073245 | chr9:9805254-9805255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58537661 | chr9:9805261-9805262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370189480 | chr9:9805265-9805266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs57345147 | chr9:9805278-9805279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185830553 | chr9:9805387-9805388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190595597 | chr9:9805396-9805397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537971437 | chr9:9805406-9805407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562868791 | chr9:9805409-9805410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144863117 | chr9:9805426-9805427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183196306 | chr9:9805446-9805447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550176168 | chr9:9805453-9805454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566980215 | chr9:9805454-9805455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188857465 | chr9:9805456-9805457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10977997 | chr9:9805496-9805497 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs568372558 | chr9:9805507-9805508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112540226 | chr9:9805510-9805511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191986395 | chr9:9805518-9805519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538490988 | chr9:9805521-9805522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558871406 | chr9:9805529-9805530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534240272 | chr9:9805631-9805632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538209865 | chr9:9805634-9805635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111231939 | chr9:9805679-9805680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555014033 | chr9:9805682-9805683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574795789 | chr9:9805769-9805770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148559790 | chr9:9805823-9805824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547463413 | chr9:9805826-9805827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554005439 | chr9:9805828-9805829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559453457 | chr9:9805841-9805842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142925983 | chr9:9805859-9805860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554167393 | chr9:9805888-9805889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182663564 | chr9:9805910-9805911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574134656 | chr9:9805919-9805920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562804833 | chr9:9805938-9805939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10816186 | chr9:9805954-9805955 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs187675617 | chr9:9805962-9805963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114197541 | chr9:9805976-9805977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189202988 | chr9:9807823-9807824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372863337 | chr9:9807837-9807838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564006305 | chr9:9807855-9807856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533067654 | chr9:9807862-9807863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1768875 | chr9:9807867-9807868 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs563341947 | chr9:9807883-9807884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370332573 | chr9:9807890-9807891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149606860 | chr9:9807906-9807907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189689119 | chr9:9807913-9807914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9805200-9806000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:9807800-9808000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr9:9820000-9821000 | Enhancers | NH-A | brain |